Lifeist Wellness Inc M5B
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.00
- Day Range
- €0.00–0.00
- 52-Week Range
- €0.00–0.10
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €281,260.44
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.01
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Lifeist Wellness Inc is a portfolio wellness company leveraging advancements in science and technology. Its portfolio of brands includes; CannMart Inc, a distributor of licensed and in-house branded adult-use cannabis and cannabis-derived products in Canada; CannMart Marketplace Inc operates CannMart.com, an online marketplace for hemp-derived CBD and accessories in the U.S.; CannMart Labs Inc, licensed facility for BHO (butane hash oil) extraction within Canada; Zest Brand, liquid Diamond vape formulations; Australian Vapes online supplier of hardware, including vaporizers, and related accessories and Mikra, a biosciences and consumer wellness company. The firm generates a majority of its revenue from the operations of CannMart.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 72
- Website
- https://www.lifeist.com
Valuation
|
Metric
|
M5B
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.01 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
M5B
|
|---|---|
Quick Ratio | 0.59 |
Current Ratio | 1.52 |
Interest Coverage | −210.67 |
Quick Ratio
M5B
Profitability
|
Metric
|
M5B
|
|---|---|
Return on Assets (Normalized) | −59.07% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −89.71% |
Return on Assets
M5B
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Bdzfwnlvps | Cfpv | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Mpznnhdsmg | Qjwcrbs | $70.8 Bil | |
HLN
| Haleon PLC ADR | Pfpgqgc | Dxt | $38.2 Bil | |
VTRS
| Viatris Inc | Jswqcytw | Vktsn | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Nxnttlwz | Hzt | $12.5 Bil | |
CTLT
| Catalent Inc | Jlvbdysx | Hrmkwl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ncrwmfwgj | Drh | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Sqlcplnmz | Kdb | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Lfvhwxszd | Pjswbyx | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Jfbkjjsnx | Nqwt | $2.9 Bil |